| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 07/20/2011 | CN101444585B Pharmaceutical composition with medicinal cosmetics, muscle fibre repairing and striae gravidarum removing effects |
| 07/20/2011 | CN101439112B Medicament for treating leukoderma |
| 07/20/2011 | CN101422597B Preparation method of trichomadesis-prevention hair-growth liquid |
| 07/20/2011 | CN101422569B Health-care preparation capable of increasing the multiplication function of marrow hemopoietic stem cells to fight against senium and anaemia |
| 07/20/2011 | CN101406594B Chinese medicine for treating tumor of lung |
| 07/20/2011 | CN101406548B Chinese medicine preparation for treating arthromeningitis and preparation technique |
| 07/20/2011 | CN101406484B Chinese medicine for promoting digestion |
| 07/20/2011 | CN101401848B Composition for treating acute, chronic hepatitis and fatty liver |
| 07/20/2011 | CN101357203B Preparation for treating cancer and carcinoma and preparation method thereof |
| 07/20/2011 | CN101301390B Health wine for releasing toxin of cigarette and producing method thereof |
| 07/20/2011 | CN101293030B Medicine liqueur for treating muscles and bones diseases |
| 07/20/2011 | CN101288706B Xanthium sibiricum honey compound soup for treating nasal sinusitis |
| 07/20/2011 | CN101279047B Oral medicament for curing cervical vertebra disease |
| 07/20/2011 | CN101279040B Chinese medicinal active anti-cancer vaccine and method of preparing the same |
| 07/20/2011 | CN101269138B Traditional Chinese medicine for treating hemorrhoid |
| 07/20/2011 | CN101264188B Orally-administered medicinal liquor for treating rheumatic arthritis and preparation thereof |
| 07/20/2011 | CN101244206B Pharmaceutical combination for treating cerebral thrombus and preparation thereof |
| 07/20/2011 | CN101244086B Method for improving supercritical CO2 abstraction propolis obtaining ratio |
| 07/20/2011 | CN101230375B Jellyfish originated glycoprotein having fatigue resistant activity and preparation technique thereof |
| 07/20/2011 | CN101214307B Chinese medicine powder medicine for treating eczema especially ear eczema |
| 07/20/2011 | CN101199663B Chinese medicine for treating psoriasis and preparing method thereof |
| 07/20/2011 | CN101199605B Detection method of Chinese medicine granules for treating diabetes |
| 07/20/2011 | CN101194960B Oral liquid for treating headache and method for preparing the same |
| 07/20/2011 | CN101181418B Medicine composition for curing arrhythmia and preparation method and detection method thereof |
| 07/20/2011 | CN101164590B Traditional Chinese medicine orally administered cream for leveling scar, eliminating striae gravidarum and wrinkle, and preparation method |
| 07/20/2011 | CN101107002B Anthelmintic composition |
| 07/20/2011 | CN101104037B Internal-applied traditional Chinese medicine for treating damp-heat type child asthma |
| 07/20/2011 | CN101019976B Hot compress medicine bag for treating osteoarthrosis |
| 07/20/2011 | CN101019576B Beatifying milk tablet |
| 07/19/2011 | US7982004 Nucleic acid and corresponding protein entitled 161P5C5 useful in treatment and detection of cancer |
| 07/19/2011 | US7981873 Use within transplantation surgery |
| 07/19/2011 | US7981859 Including teicoplanin which shares many chemical and microbiological characteristics with vancomycin, but which possesses higher activity against many Gram-positive bacteria and is less nephrotoxic |
| 07/19/2011 | US7981673 Process for the maturation of dendritic cells and a vaccine |
| 07/19/2011 | US7981671 Use of triplex structure DNA in transferring nucleotide sequences |
| 07/19/2011 | US7981446 Pharmaceutical compositions and methods for delivering nucleic acids into cells |
| 07/19/2011 | US7981434 Surface exposed immunoglobulin D-binding protein from Moraxella catarrhalis |
| 07/19/2011 | CA2467046C Process for the manufacture of human mononuclear phagocytic leukocytes |
| 07/19/2011 | CA2440890C Tumor therapy with alphavirus-based and high affinity laminin receptor-targeted vectors |
| 07/19/2011 | CA2341441C Methods of using and compositions comprising dopamine reuptake inhibitors |
| 07/19/2011 | CA2188560C Compositions comprising dna damaging agents and p53 |
| 07/19/2011 | CA1341618C Isolation cloning and expression of primate gm-csf |
| 07/14/2011 | WO2011084925A2 Biomaterials made from human hair |
| 07/14/2011 | WO2011084747A2 Compositions and methods for somatic tissue induced pluripotent stem cells having an endoderm origin |
| 07/14/2011 | WO2011083881A1 Vaccine for treatment of tautopathy |
| 07/14/2011 | WO2011083853A1 Anti-atopic dermatitis agent |
| 07/14/2011 | WO2011083827A1 Cerebral nerve cell neogenesis agent |
| 07/14/2011 | WO2011083738A1 Dna damage repair promoter for oral application, and elastase activity inhibitor for oral application |
| 07/14/2011 | WO2011083477A1 Immuno-tolerance formulations |
| 07/14/2011 | WO2011022071A3 Cardiac compositions |
| 07/14/2011 | WO2011022070A3 Perivascular stem cell composition for bone |
| 07/14/2011 | WO2010096564A4 Dietary supplements containing polyunsaturated omega-3 fatty acids and probiotic bacteria with potential gastrointestinal and dermatological benefits |
| 07/14/2011 | US20110173711 eNos Mutations Useful for Gene Therapy and Therapeutic Screening |
| 07/14/2011 | US20110172121 Allogeneic stem cell bank |
| 07/14/2011 | US20110171726 Multipotent stem cells derived from human adipose tissue and cellular therapeutic agents comprising the same |
| 07/14/2011 | US20110171453 Immunoneutral silk-fiber-based medical devices |
| 07/14/2011 | US20110171317 Method for inhibiting accumulation of visceral fat |
| 07/14/2011 | US20110171283 Composition containing at least one nutrivite, at least one disinfecting or decontaminating, and/or at least one protease-inhibiting active compound and/or active compound complex |
| 07/14/2011 | US20110171281 Soft capsule composition and method of use |
| 07/14/2011 | US20110171265 Composition Comprising Parasite Eggs and Methods for Isolation and Storage of Parasite Eggs |
| 07/14/2011 | US20110171264 Protein Formulation |
| 07/14/2011 | US20110171262 Parvoviral capsid with incorporated gly-ala repeat region |
| 07/14/2011 | US20110171256 Viral strains derived from the vaccinia virus lister vacv-107 and uses thereof |
| 07/14/2011 | US20110171239 pH INDUCED SILK GELS AND USES THEREOF |
| 07/14/2011 | US20110171232 Methods of treating autoimmune diseases caused by small intestinal bacterial overgrowth |
| 07/14/2011 | US20110171228 Methods and Compositions Relating to the Regulation of Apoptosis by MUC1 and BH3-Containing Proapoptotic Proteins |
| 07/14/2011 | US20110171207 Compositions and methods for treating inflammation and auto-immune diseases |
| 07/14/2011 | US20110171187 Dietary supplements for promotion of growth, repair, and maintenance of bone and joints |
| 07/14/2011 | US20110171186 Chondrocyte therapeutic delivery system |
| 07/14/2011 | US20110171185 Genetically intact induced pluripotent cells or transdifferentiated cells and methods for the production thereof |
| 07/14/2011 | US20110171184 Method for Introducing a Pna Molecule Conjugated to a Positively Charged Peptide into the Cytosol and/or the Nucleus by Photochemical Internalisation (Pci) |
| 07/14/2011 | US20110171183 Markers of Induced Pluripotent Stem Cells |
| 07/14/2011 | US20110171182 Methods for cell expansion and uses of cells and conditioned media produced thereby for therapy |
| 07/14/2011 | US20110171181 Methods for modifying vascular vessel walls |
| 07/14/2011 | US20110171180 Bioengineered skin substitutes |
| 07/14/2011 | US20110171179 Method for Regulating Production of Hemoglobin Beta Chains |
| 07/14/2011 | US20110171170 Cytotoxic t cell defined egfr peptide and an optimized derivative peptide |
| 07/14/2011 | US20110171127 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer |
| 07/14/2011 | US20110167602 Immunoneutral silk-fiber-based medical devices |
| 07/14/2011 | CA2786400A1 Biomaterials made from human hair |
| 07/13/2011 | EP2343086A2 Antibodies to CD40 |
| 07/13/2011 | EP2343079A2 Cell suspension preparation device |
| 07/13/2011 | EP2342979A2 Composition for improving membrane composition and functioning of cells |
| 07/13/2011 | EP2342978A2 Composition for improving membrane composition and functioning of cells |
| 07/13/2011 | EP2342975A2 Composition for improving membrane composition and functioning of cells |
| 07/13/2011 | EP2342198A1 Salts of n-[6-cis-2,6-dimethylmorpholin-4yl)pyridine-3yl]-2-methyl-4'-(trifluoromethoxy)[1,1'-biphenyl]-3-carboxamide |
| 07/13/2011 | EP2341925A1 Composition of thrombolytic agent and anti thrombosis and also its production method |
| 07/13/2011 | EP2341916A1 Colostrum composition |
| 07/13/2011 | EP2341906A2 Hematopoietic protection against ionizing radiation using selective cyclin-dependent kinase 4/6 inhibitors |
| 07/13/2011 | EP2341784A1 Nutritional compositions with coated lipid globules |
| 07/13/2011 | EP2084508B1 Preparation method |
| 07/13/2011 | EP1289553B1 Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 07/13/2011 | EP0979080B1 A method of modulating an immune response in an infected mammal by transmucosal administration of modulating agent |
| 07/13/2011 | CN1922309B A respiratory syncytial virus with a genomic deficiency complemented in trans |
| 07/13/2011 | CN1872216B Medication composition for treating headache, and preparation method |
| 07/13/2011 | CN102123718A Treatment of gut motility disorders |
| 07/13/2011 | CN102123717A Methods of treating inflammatory colon diseases |
| 07/13/2011 | CN102123715A Immune system stimulating nutrition |
| 07/13/2011 | CN102123693A Use of hydrogen peroxide-producing bacteria for tooth whitening |
| 07/13/2011 | CN102123615A Temperature-induced delivery of nutrients by micro-organisms in the gastrointestinal tract |
| 07/13/2011 | CN102123604A Probiotic chewing gum method of manufacture |